| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 4 | |
| #3 | Australia | 3 | |
| #4 | China | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | Singapore | 3 | |
| #7 | Canada | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | South Africa | 2 | |
| #10 | Brazil | 1 | |
| #11 | Finland | 1 | |
| #12 | Japan | 1 | |
| #13 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Therapeutic chemical compounds | |
| #5 | Measuring microorganism processes | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hemminki Akseli | 27 |
| #2 | Cerullo Vincenzo | 14 |
| #3 | Tähtinen Siri | 13 |
| #4 | Liikanen Ilkka | 9 |
| #5 | Siurala Mikko | 9 |
| #6 | Parviainen Suvi | 9 |
| #7 | Tahtinen Siri | 8 |
| #8 | Vähä-Koskela Markus | 8 |
| #9 | Akseli Hemminki | 4 |
| #10 | Vaha-Koskela Markus | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021069806A1 | An oncolytic virus vector coding for variant interleukin-2 (vil-2) polypeptide | |
| US2020399615A1 | Enhanced adoptive cell therapy | |
| WO2020249873A1 | Oncolytic adenovirus and checkpoint inhibitor combination therapy | |
| WO2018078220A1 | Interleukin 8 (il-8) as a prognostic and predictive biomarker and compositions and vectors for use in oncolytic immunotherapy | |
| AU2016232009A1 | Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related thereto | |
| CN111658670A | Oncolytic adenoviral vectors and adoptive T cell therapeutic compositions and uses thereof |